TY - JOUR
T1 - Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study
AU - Chen, Teresa K.
AU - Estrella, Michelle M.
AU - Katz, Ronit
AU - Sarnak, Mark J.
AU - Grams, Morgan E.
AU - Cushman, Mary
AU - Levitan, Emily B.
AU - Parikh, Chirag R.
AU - Kimmel, Paul L.
AU - Bonventre, Joseph V.
AU - Coca, Steven G.
AU - Gutiérrez, Orlando M.
AU - Ix, Joachim H.
AU - Shlipak, Michael G.
N1 - Publisher Copyright:
Copyright © 2024 by the American Society of Nephrology.
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Key PointsIn diabetes and CKD, creatinine-and cystatin C-based eGFR has a strong inverse correlation with plasma TNF receptor 1, TNF receptor 2, and soluble urokinase-Type plasminogen activator receptor.Higher plasma soluble TNF receptors 1 and 2 and soluble urokinase-Type plasminogen activator receptor were each individually associated with mortality, independent of baseline kidney measures.BackgroundSeveral plasma biomarkers of kidney health have been associated with CKD progression in persons with diabetes, but their associations with mortality risk have been largely unexplored.MethodsIn a random sample of 594 participants with diabetes and creatinine-based eGFR <60 ml/min per 1.73 m2 from the REGARDS cohort study, Cox proportional hazards regression was used to determine hazard ratios of mortality by plasma concentrations of soluble TNF receptors 1 and 2 (TNFR1 and TNFR2), soluble urokinase-Type plasminogen activator receptor (suPAR), kidney injury molecule 1 (KIM-1), chitinase 3-like 1 (YKL-40), and monocyte chemotactic protein 1 (MCP-1). Covariates included sociodemographic and clinical factors, urine albumin-To-creatinine ratio (UACR), and creatinine-and cystatin C-based eGFR (eGFRcr-cys).ResultsAt baseline, the mean age was 70 years, 47% were male, 53% self-identified as Black, mean±SD eGFRcr-cys was 41±13 ml/min per 1.73 m2, and median (interquartile range) UACR was 32 (9-224) mg/g. Correlations with eGFRcr-cys were stronger for TNFR1, TNFR2, and suPAR (r=-0.72 to-0.76) than for KIM-1, YKL-40, and MCP-1 (r=-0.10 to-0.40). With a median follow-up of 7 years, 332 participants died. In models adjusted for sociodemographic and clinical factors, each SD higher baseline concentration of plasma TNFR1 (hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.20 to 1.38), TNFR2 (HR, 1.61; 95% CI, 1.42 to 1.82), suPAR (HR, 1.33; 95% CI, 1.22 to 1.44), KIM-1 (HR, 1.20; 95% CI, 1.08 to 1.33), and YKL-40 (HR, 1.23; 95% CI, 1.11 to 1.38) was associated with higher risk of all-cause mortality, whereas MCP-1 was not. Upon further adjustment for baseline eGFRcr-cys and UACR, only the associations for TNFR1 (HR, 1.16; 95% CI, 1.04 to 1.29), TNFR2 (HR, 1.34; 95% CI, 1.12 to 1.60), and suPAR (HR, 1.23; 95% CI, 1.11 to 1.36) persisted.ConclusionsAmong adults with diabetes and CKD, higher plasma TNFR1, TNFR2, and suPAR were associated with all-cause mortality, independent of baseline kidney function.
AB - Key PointsIn diabetes and CKD, creatinine-and cystatin C-based eGFR has a strong inverse correlation with plasma TNF receptor 1, TNF receptor 2, and soluble urokinase-Type plasminogen activator receptor.Higher plasma soluble TNF receptors 1 and 2 and soluble urokinase-Type plasminogen activator receptor were each individually associated with mortality, independent of baseline kidney measures.BackgroundSeveral plasma biomarkers of kidney health have been associated with CKD progression in persons with diabetes, but their associations with mortality risk have been largely unexplored.MethodsIn a random sample of 594 participants with diabetes and creatinine-based eGFR <60 ml/min per 1.73 m2 from the REGARDS cohort study, Cox proportional hazards regression was used to determine hazard ratios of mortality by plasma concentrations of soluble TNF receptors 1 and 2 (TNFR1 and TNFR2), soluble urokinase-Type plasminogen activator receptor (suPAR), kidney injury molecule 1 (KIM-1), chitinase 3-like 1 (YKL-40), and monocyte chemotactic protein 1 (MCP-1). Covariates included sociodemographic and clinical factors, urine albumin-To-creatinine ratio (UACR), and creatinine-and cystatin C-based eGFR (eGFRcr-cys).ResultsAt baseline, the mean age was 70 years, 47% were male, 53% self-identified as Black, mean±SD eGFRcr-cys was 41±13 ml/min per 1.73 m2, and median (interquartile range) UACR was 32 (9-224) mg/g. Correlations with eGFRcr-cys were stronger for TNFR1, TNFR2, and suPAR (r=-0.72 to-0.76) than for KIM-1, YKL-40, and MCP-1 (r=-0.10 to-0.40). With a median follow-up of 7 years, 332 participants died. In models adjusted for sociodemographic and clinical factors, each SD higher baseline concentration of plasma TNFR1 (hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.20 to 1.38), TNFR2 (HR, 1.61; 95% CI, 1.42 to 1.82), suPAR (HR, 1.33; 95% CI, 1.22 to 1.44), KIM-1 (HR, 1.20; 95% CI, 1.08 to 1.33), and YKL-40 (HR, 1.23; 95% CI, 1.11 to 1.38) was associated with higher risk of all-cause mortality, whereas MCP-1 was not. Upon further adjustment for baseline eGFRcr-cys and UACR, only the associations for TNFR1 (HR, 1.16; 95% CI, 1.04 to 1.29), TNFR2 (HR, 1.34; 95% CI, 1.12 to 1.60), and suPAR (HR, 1.23; 95% CI, 1.11 to 1.36) persisted.ConclusionsAmong adults with diabetes and CKD, higher plasma TNFR1, TNFR2, and suPAR were associated with all-cause mortality, independent of baseline kidney function.
KW - CKD
KW - diabetic kidney disease
KW - mortality risk
UR - http://www.scopus.com/inward/record.url?scp=85212055011&partnerID=8YFLogxK
U2 - 10.2215/CJN.0000000000000544
DO - 10.2215/CJN.0000000000000544
M3 - Article
C2 - 39652331
AN - SCOPUS:85212055011
SN - 1555-9041
VL - 19
SP - 1585
EP - 1593
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 12
ER -